vaccines

IntroductionNatural products, especially polyphenol-rich medicinal plants, are increasingly investigated as multitarget therapeutics in both human and veterinary medicine for angiogenic regenerative properties and for inflammation based-diseases. Recent developments in natural product formulation, notably microencapsulation, have been shown to improve stability, bioavailability, and controlled re…

As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current outbreak

Brazilian authorities have stressed that the 42 cases of severe adverse events out of half-a-million vaccinated represent only 0.008%. There is no doubt that it is a small risk at the population level. At the individual level, however, even one life lost to a severe adverse event is one too many

For many people, the flu is an unpleasant but temporary illness. A few days of fever, cough, sore throat, body aches, and fatigue are followed by recovery and a return to normal life. However, for older adults, influenza can be much more dangerous. What starts as a simple infection can quickly develop into serious complications […] The post A Stronger Flu Vaccine Could Offer Better Protection for…

Every year, influenza, commonly known as the flu, affects millions of people around the world. For many people, the illness causes several days of coughing, sneezing, fever, fatigue, headaches, and muscle aches before they recover. Most healthy adults begin feeling better within a week or two. However, the flu is far more than just a […] The post Why One Flu Shot May Keep More Older People Out of…

Candida auris is an emerging multidrug-resistant fungal pathogen posing a major global health threat. In this study, we employed a targeted drug-repurposing strategy to identify novel indications for existing FDA-approved compounds against C. auris, leading to the identification of Tavaborole as a potent fungistatic agent. Tavaborole displayed robust activity across all five tested clades of C. a…

Feeling abandoned and overwhelmed, families are turning to controversial new therapies backed by the US health secretary Landyn Holdren is an eight-year-old autistic child who has high support needs and is nonspeaking. His mother, Christy Holdren, says he can be self-harming, slapping his chest, face or head when distressed. Later this month, she will spend $15,000 on an unapproved stem cell trea…

Nature Communications, Published online: 12 June 2026; doi:10.1038/s41467-026-74194-7 Polysaccharide vaccines are crucial to immunize against bacterial infections but require efficacious adjuvants to induce protective immune responses. Here the authors explore the use of Pam3CSK4 as an adjuvant for polysaccharide vaccines in mouse and non-human primate models.

A multilingual benchmark of 1,886 vaccine-related questions found that large language models answered most items accurately across English, Spanish, and Chinese. However, performance varied by vaccine type, language, and prompting method, with persistent errors in dosing, contraindications, age eligibility, and other clinically sensitive guidance.

In a study published in The Lancet, researchers at The University of Texas Medical Branch (UTMB) report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus after a single dose.

The internet has made health information easier to access than ever before. Unfortunately, it has also made it easier for misinformation to spread. During health emergencies, inaccurate advice can sometimes travel faster than scientific evidence. A new study examining the 2025 measles outbreak in the United States provides a striking example of how this can […] The post How Measles Misinformation…

One-off programme to begin in July after recent MenB outbreaks in Kent, Dorset and Berkshire killed three people Teenagers in their final school year and young people starting university will be offered two doses of a vaccine to protect them against meningitis B, the government has announced. The one-off vaccination programme, which will begin in late July, comes after an unprecedented outbreak o…

BackgroundSuzetrigine (Journavx; VX-548), the first selective NaV1.8 voltage-gated sodium channel inhibitor approved by the FDA on 30 January 2025, represents a novel non-opioid option for moderate-to-severe acute pain. Given its recent market entry and unique peripheral mechanism, comprehensive post-marketing safety surveillance is essential.ObjectiveThis study aimed to identify and characterize…

Vaccination remains the priority, but some researchers are looking for drugs to fight the virus in people who don't get the shot.

Repeated doses of a tuberculosis vaccine lowered insulin needs in patients with two forms of diabetes, new trial data show. But more research is needed to prove the benefit.